Bill > S711

This bill aims to improve breast cancer equity and early detection in Massachusetts. The key provisions are: 1. Requiring the Group Insurance Commission, Medicaid, and private insurers to cover diagnostic examinations for breast cancer and digital breast tomosynthesis screening at the same level as screening mammograms, without allowing an increase in patient cost-sharing. 2. Defining "diagnostic examinations for breast cancer" as medically necessary tests to evaluate abnormalities detected through screening or other means, including diagnostic mammography, digital breast tomosynthesis, breast MRI, or breast ultrasound. 3. Exempting high-deductible health plans (HSA-qualified policies) from certain cost-sharing requirements, except for those related to preventive care as defined by federal regulations. 4. Setting the effective date for the new coverage requirements as January 1, 2025 for all new, renewed, or amended insurance contracts. The goal of this bill is to ensure equitable access to comprehensive breast cancer screening and diagnostic services, with the aim of improving early detection and treatment outcomes.

Business and Industry, Health and Social Services

https://malegislature.gov/Bills/193/S711